TIMP2 and fatty liver disease: Background: Activation of hepatic stellate cells (HSCs) in response to liver injury increases extracellular matrix (ECM) deposition and upregulation of tissue inhibitor of metalloproteinase-2 (TIMP-2), promoting fibrogenesis, a key feature of metabolic dysfunction-associated fatty liver disease (MAFLD).